DBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark. (Q50547499)

15 March 2018

editorial

0 references

title

DBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark. (English)

1 reference

15 March 2018

0 references

Jens Overgaard

1

1 reference

15 March 2018

publication date

1 January 2008

1 reference

15 March 2018

published in

Acta Oncologica

1 reference

15 March 2018

volume

47

1 reference

15 March 2018

issue

4

1 reference

15 March 2018

page(s)

491-496

1 reference

15 March 2018

I. The Results of Radical Operations for the Cure of Carcinoma of the Breast

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Clinical oncology: the future of radiotherapy and medical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Danish Breast Cancer Cooperative Group--DBCG: History, organization, and status of scientific achievements at 30-year anniversary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Impact of standardization of estrogen and progesterone receptor assays of breast cancer biopsies in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studie

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Karnofsky Memorial Lecture. Natural history of small breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Cardiac exposures in breast cancer radiotherapy: 1950s-1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Genetic markers for prediction of normal tissue toxicity after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Development of new predictive markers for endocrine therapy and resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

TIMP-1 as a tumor marker in breast cancer--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Organized nation-wide implementation of sentinel lymph node biopsy in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Sentinel node biopsy in breast cancer: five years experience from Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802068607

10.1080/02841860802068607

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018